Relapsed/Refractory Multiple Myeloma in 2020/2021 and Beyond

SIMPLE SUMMARY: During the last two decades, collaborative translational studies utilizing novel methodologies have dramatically advanced our understanding of multiple myeloma (MM) pathophysiology and revolutionized derived treatment strategies. Nevertheless, MM remains an incurable disease, with th...

Descripción completa

Detalles Bibliográficos
Autores principales: Podar, Klaus, Leleu, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534171/
https://www.ncbi.nlm.nih.gov/pubmed/34680303
http://dx.doi.org/10.3390/cancers13205154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534171/
https://www.ncbi.nlm.nih.gov/pubmed/34680303
http://dx.doi.org/10.3390/cancers13205154

Ejemplares similares